aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;K562;CHEMBL700266;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxic activity against K562 erythroleukemic cells;CHEMBL1132317;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL926687;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Oral bioavailability in human;CHEMBL1141299;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;K562;CHEMBL927383;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 5 days by XTT assay;CHEMBL1141448;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;;CHEMBL1035433;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total body clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1035434;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL1266185;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay;CHEMBL1255231;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1267245;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267246;[];Plasmodium falciparum 7G8;[];;;57266.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267247;[];Plasmodium falciparum D10;[];;;478861.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267248;[];Plasmodium falciparum;[];Dd2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267249;[];Plasmodium falciparum;[];GB4;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267250;[];Plasmodium falciparum HB3;[];;;137071.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267251;[];Plasmodium falciparum;[];W2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1614114;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1816;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Direct protein target assigned;D;2585;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL1614134;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). (Class of assay: confirmatory) [Related pubchem assays: 2118 (Project Summary), 2098 (Primary HTS)];CHEMBL1201862;Direct protein target assigned;D;2382;7;CHEMBL5313;;
CLD0;confirmatory;;CHEMBL1614164;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Fluorescence Cell-Based Retest of Candida albicans Growth in the Presence of Fluconazole. (Class of assay: confirmatory) [Related pubchem assays: 2007 (Project Summary), 1979 (Primary HTS)];CHEMBL1201862;Default value - Target has yet to be curated;U;2467;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614166;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2675;7;CHEMBL1293317;;
CLD0;confirmatory;;CHEMBL1614171;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1967;7;CHEMBL1293298;;
CLD0;confirmatory;;CHEMBL1614234;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ];CHEMBL1201862;Direct protein target assigned;D;1457;7;CHEMBL1293238;;
CLD0;confirmatory;;CHEMBL1614236;[];Influenza A virus (A/WSN/1933(H1N1));[];;;382835.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2326;7;CHEMBL1293303;;
CLD0;confirmatory;;CHEMBL1614250;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1468;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1614310;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1459;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614316;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2666;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614521;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]";CHEMBL1201862;Direct protein target assigned;D;1454;7;CHEMBL4040;;
CLD0;confirmatory;;CHEMBL1614522;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]";CHEMBL1201862;Direct protein target assigned;D;2364;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL1614524;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)];CHEMBL1201862;Default value - Target has yet to be curated;U;1934;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613794;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Fluorescence Cell-Based Secondary Assay for toxicity in mammalian fibroblasts. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007];CHEMBL1201862;Default value - Target has yet to be curated;U;2327;7;CHEMBL612545;;
CLD0;confirmatory;MEF;CHEMBL1613805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307598;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2668;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614198;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1815;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614207;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1877;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1768;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614263;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Quantitative High-Throughput Screen for Regulators of Epigenetic Control. (Class of assay: confirmatory) [Related pubchem assays: 1041, 1039, 890, 1036, 1653, 1035, 1043, 1038, 990, 597, 1042, 1037 ];CHEMBL1201862;Default value - Target has yet to be curated;U;1865;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1707, 1708 ];CHEMBL1201862;Direct protein target assigned;D;1705;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614328;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2585 (qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Default value - Target has yet to be curated;U;2712;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614330;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)];CHEMBL1201862;Direct protein target assigned;D;2353;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1614342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485313;7;CHEMBL1293277;;
CLD0;confirmatory;;CHEMBL1614410;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)];CHEMBL1201862;Direct protein target assigned;D;2662;7;CHEMBL1293299;;
CLD0;confirmatory;;CHEMBL1614466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) ), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 2517 (qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)];CHEMBL1201862;Direct protein target assigned;D;2572;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1766;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614537;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1882;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614538;[];Streptococcus;[];;;1301.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1900 (Counter Screen), 1677 (Project Summary), 1902 (Retest at Dose), 1662 (Primary HTS)];CHEMBL1201862;Non-molecular target assigned;N;1915;7;CHEMBL612313;;
CLD0;confirmatory;;CHEMBL1614544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1487;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614554;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1469;7;CHEMBL1947;;
CLD0;confirmatory;;CHEMBL1613829;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Direct protein target assigned;D;2549;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1613897;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Default value - Target has yet to be curated;U;2711;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613900;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1876;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1613914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2147;7;CHEMBL1293226;;
CLD0;confirmatory;;CHEMBL1613918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ];CHEMBL1201862;Direct protein target assigned;D;1688;7;CHEMBL5514;;
CLD0;confirmatory;;CHEMBL1613970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1948;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613983;[];Streptococcus;[];;;1301.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)];CHEMBL1201862;Non-molecular target assigned;N;1900;7;CHEMBL612389;;
CLD0;confirmatory;BJ;CHEMBL1614004;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)];CHEMBL1201862;Non-molecular target assigned;N;1933;7;CHEMBL614358;;
CLD0;confirmatory;;CHEMBL1614009;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2660;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614064;[];Streptococcus pyogenes M1 GAS;[];;;160490.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)];CHEMBL1201862;Homologous protein target assigned;H;1902;7;CHEMBL1293228;;
CLD0;confirmatory;;CHEMBL1614067;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Direct protein target assigned;D;2528;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL1614079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485314;7;CHEMBL2392;;
CLD0;confirmatory;;CHEMBL1614087;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2551;7;CHEMBL1293231;;
CLD0;confirmatory;;CHEMBL1614141;[];Streptococcus pyogenes M1 GAS;[];;;160490.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1902 (Retest at Dose), 1900 (Counter Screen), 1662 (Primary HTS)];CHEMBL1201862;Homologous protein target assigned;H;1914;7;CHEMBL1293228;;
CLD0;confirmatory;;CHEMBL1614142;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1886;7;CHEMBL3879801;;
CLD0;confirmatory;BJ;CHEMBL1614155;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)];CHEMBL1201862;Non-molecular target assigned;N;1936;7;CHEMBL614358;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614291;[];Equus caballus;[];;;9796.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Identification of Novel General Anesthetics. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2323;7;CHEMBL1293254;;
CLD0;confirmatory;;CHEMBL1614293;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2667;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614298;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Cell cycle validation with wells to cells screening paradigm. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;2441;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614362;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Validation screen for inhibitors of Lassa infection. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;463096;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614421;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1460;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1614433;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ];CHEMBL1201862;Homologous protein target assigned;H;1708;7;CHEMBL1293285;;
CLD0;confirmatory;BJ;CHEMBL1614499;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)];CHEMBL1201862;Non-molecular target assigned;N;1935;7;CHEMBL614358;;
CLD0;confirmatory;;CHEMBL1614502;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Homologous protein target assigned;H;1463;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1613767;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1883;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1613776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1479;7;CHEMBL1947;;
CLD0;confirmatory;;CHEMBL1613838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485297;7;CHEMBL1293294;;
CLD0;confirmatory;;CHEMBL1613842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1458;7;CHEMBL1293232;;
CLD0;confirmatory;;CHEMBL1613927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a)];CHEMBL1201862;Direct protein target assigned;D;463106;7;CHEMBL1293227;;
CLD0;confirmatory;;CHEMBL1613928;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Direct protein target assigned;D;2708;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1613941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;463097;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL1614019;[];Drosophila;[];;;7215.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1519;7;CHEMBL612545;;
CLD0;;;CHEMBL1614670;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614671;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction unbound in human after iv administration;CHEMBL1614632;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1614673;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mean residence time in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614674;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Half life in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1654778;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654779;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654780;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654781;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654782;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654783;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697855;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset;CHEMBL1697821;Non-molecular target assigned;N;;1;CHEMBL1626541;;
CLD0;confirmatory;;CHEMBL1614448;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485388, AID493005];CHEMBL1201862;Direct protein target assigned;D;485342;7;CHEMBL6157;;
CLD0;confirmatory;;CHEMBL1738091;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488989, AID488993, AID488995];CHEMBL1201862;Direct protein target assigned;D;488982;7;CHEMBL2056;;
CLD0;confirmatory;;CHEMBL1614221;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774];CHEMBL1201862;Non-molecular target assigned;N;488745;7;CHEMBL364;;
CLD0;confirmatory;HEK-293T;CHEMBL1738479;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489020, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489019;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614045;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774];CHEMBL1201862;Non-molecular target assigned;N;488752;7;CHEMBL364;;
CLD0;confirmatory;HEK-293T;CHEMBL1738599;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489019, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489020;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504591];CHEMBL1201862;Direct protein target assigned;D;504536;7;CHEMBL2288;;
CLD0;confirmatory;SW480;CHEMBL1738636;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463097, AID463113, AID493165, AID493166, AID504806, AID504809];CHEMBL1201862;Direct protein target assigned;D;504364;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL1738675;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493125, AID504467];CHEMBL1201862;Direct protein target assigned;D;493107;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1737859;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488989, AID488993, AID488995];CHEMBL1201862;Direct protein target assigned;D;488981;7;CHEMBL2056;;
CLD0;confirmatory;;CHEMBL1613922;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;488816;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL1737868;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466];CHEMBL1201862;Direct protein target assigned;D;493106;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1737991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402];CHEMBL1201862;Direct protein target assigned;D;504339;7;CHEMBL5896;;
CLD0;confirmatory;;CHEMBL1737994;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444];CHEMBL1201862;Default value - Target has yet to be curated;U;504648;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489034;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614315;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939];CHEMBL1201862;Direct protein target assigned;D;488837;7;CHEMBL1293275;;
CLD0;confirmatory;;CHEMBL1614194;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485296];CHEMBL1201862;Homologous protein target assigned;H;485295;7;CHEMBL3897;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1738565;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488989, AID488993, AID488995];CHEMBL1201862;Direct protein target assigned;D;488983;7;CHEMBL2056;;
CLD0;confirmatory;;CHEMBL1738574;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388];CHEMBL1201862;Direct protein target assigned;D;493005;7;CHEMBL6157;;
CLD0;confirmatory;;CHEMBL1738606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398];CHEMBL1201862;Direct protein target assigned;D;504327;7;CHEMBL5501;;
CLD0;confirmatory;;CHEMBL1614279;[];Trypanosoma brucei;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961];CHEMBL1201862;Homologous protein target assigned;H;485368;7;CHEMBL5686;;
CLD0;confirmatory;;CHEMBL1738610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962];CHEMBL1201862;Direct protein target assigned;D;488953;7;CHEMBL1741193;;
CLD0;confirmatory;Jurkat;CHEMBL1738197;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029];CHEMBL1201862;Non-molecular target assigned;N;489004;7;CHEMBL397;;
CLD0;confirmatory;;CHEMBL1738402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;488949;7;CHEMBL1741210;;
CLD0;confirmatory;;CHEMBL1613775;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771, AID488772];CHEMBL1201862;Direct protein target assigned;D;488773;7;CHEMBL6035;;
CLD0;confirmatory;;CHEMBL1794367;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380];CHEMBL1201862;Homologous protein target assigned;H;588378;7;CHEMBL1795085;;
CLD0;confirmatory;HEK293;CHEMBL1794308;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249];CHEMBL1201862;Non-molecular target assigned;N;540256;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794311;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855];CHEMBL1201862;Homologous protein target assigned;H;504847;7;CHEMBL1977;;
CLD0;confirmatory;;CHEMBL1794375;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278];CHEMBL1201862;Default value - Target has yet to be curated;U;540276;7;CHEMBL612545;;
CLD0;confirmatory;SH-SY5Y;CHEMBL1794380;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307740;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588378, AID588380];CHEMBL1201862;Non-molecular target assigned;N;588349;7;CHEMBL614910;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;BJ;CHEMBL1794410;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1554, AID1674];CHEMBL1201862;Non-molecular target assigned;N;2631;7;CHEMBL614358;;
CLD0;confirmatory;;CHEMBL1794424;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771];CHEMBL1201862;Homologous protein target assigned;H;588453;7;CHEMBL6035;;
CLD0;confirmatory;;CHEMBL1794461;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous protein complex subunits assigned;6;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262];CHEMBL1201862;Homologous protein target assigned;H;540253;7;CHEMBL3885569;;
CLD0;confirmatory;;CHEMBL1794467;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878];CHEMBL1201862;Homologous protein target assigned;H;504865;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL1794483;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623];CHEMBL1201862;Homologous protein target assigned;H;588590;7;CHEMBL5391;;
CLD0;confirmatory;;CHEMBL1794486;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813];CHEMBL1201862;Homologous protein target assigned;H;588795;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL1794499;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856];CHEMBL1201862;Homologous protein target assigned;H;504845;7;CHEMBL1795091;;
CLD0;confirmatory;;CHEMBL1794536;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638];CHEMBL1201862;Homologous protein target assigned;H;588579;7;CHEMBL5365;;
CLD0;confirmatory;HepG2;CHEMBL1794553;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860];CHEMBL1201862;Non-molecular target assigned;N;588856;7;CHEMBL395;;
CLD0;confirmatory;;CHEMBL1794569;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636];CHEMBL1201862;Homologous protein target assigned;H;588591;7;CHEMBL5542;;
CLD0;confirmatory;;CHEMBL1794573;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588834;7;CHEMBL240;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860];CHEMBL1201862;Homologous protein target assigned;H;588855;7;CHEMBL1293258;;
CLD0;confirmatory;;CHEMBL1794585;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;504891;7;CHEMBL2288;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;confirmatory;Schwann;CHEMBL1964055;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624044;7;CHEMBL2007624;;
CLD0;confirmatory;Schwann;CHEMBL1964081;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624032;7;CHEMBL2007624;;
CLD0;confirmatory;;CHEMBL1963863;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;602310;7;CHEMBL1741217;;
CLD0;confirmatory;Schwann;CHEMBL1963912;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: S16 Schwann cell viability assay (CellTiter-Glo assay). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624031;7;CHEMBL612545;;
CLD0;;GLC-4/ADR;CHEMBL2076449;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3833703;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of DNP-SG uptake (DNP-SG: 0.01 uM, Idarbicin: 10 uM) in membrane vesicles from GLC4/ADR cells;CHEMBL2074115;Homologous protein target assigned;H;2263;18;CHEMBL3004;;
CLD0;;HepG2;CHEMBL2092591;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;HARVARD: Cytotoxicity in HepG2 cell line;CHEMBL2092589;Non-molecular target assigned;N;1;19;CHEMBL395;;
CLD0;;HepG2;CHEMBL2092592;[];Plasmodium berghei;[];ANKA;;5821.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307718;Target assigned is non-molecular;1;HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells;CHEMBL2092589;Non-molecular target assigned;N;2;19;CHEMBL612653;;
CLD0;;;CHEMBL2092593;[];Plasmodium falciparum;[];3D7;;5833.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection;CHEMBL2092589;Non-molecular target assigned;N;3;19;CHEMBL364;;
CLD0;;;CHEMBL2092594;[];Plasmodium falciparum;[];Dd2;;5833.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection;CHEMBL2092589;Non-molecular target assigned;N;4;19;CHEMBL364;;
CLD0;confirmatory;;CHEMBL2114847;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624160;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114861;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624418;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114715;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624162;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;SW480;CHEMBL2114780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624297;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651635;7;CHEMBL1795085;;
CLD0;confirmatory;;CHEMBL2114788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624417;7;CHEMBL1784;;
CLD0;confirmatory;;CHEMBL2114796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651768;7;CHEMBL2146312;;
CLD0;confirmatory;;CHEMBL2114914;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624161;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114924;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624246;7;CHEMBL1293191;;
CLD0;;DA-3;CHEMBL2345812;[];Mus musculus;[];;Lysosome;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cellular uptake in mouse DA-3 cell lysosome at 10 uM after 30 mins by LysoTracker green staining-based confocal microscopic analysis relative to control;CHEMBL2331546;Default value - Target has yet to be curated;U;556603;1;CHEMBL612558;;
CLD0;;DA-3;CHEMBL2345813;[];Mus musculus;[];;Mitochondria;10090.0;;;A;ADME;BAO_0000252;mitochondrion format;;Default value - Target unknown or has yet to be assigned;0;Cellular uptake in mouse DA-3 cell mitochondria at 10 uM after 30 mins by mitotracker red staining-based confocal microscopic analysis;CHEMBL2331546;Default value - Target has yet to be curated;U;556605;1;CHEMBL612558;;
CLD0;;DA-3;CHEMBL2345814;[];Mus musculus;[];;Nucleus;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cellular uptake in mouse DA-3 cell nucleus at 10 uM after 30 mins by DRAQ5 deep red staining-based confocal microscopic analysis relative to control;CHEMBL2331546;Default value - Target has yet to be curated;U;556601;1;CHEMBL612558;;
CLD0;;;CHEMBL2345815;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of idarubicin IC50 to compound IC50 for displacement of YOYO1 from phage lambda DNA;CHEMBL2331546;Default value - Target has yet to be curated;U;556576;1;CHEMBL612545;;
CLD0;;;CHEMBL2345816;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of idarubicin IC50 to compound IC50 for displacement of SYBR from phage lambda DNA;CHEMBL2331546;Default value - Target has yet to be curated;U;556574;1;CHEMBL612545;;
CLD0;;;CHEMBL2345817;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of doxorubicin IC50 to compound IC50 for displacement of SYBR from phage lambda DNA;CHEMBL2331546;Default value - Target has yet to be curated;U;556572;1;CHEMBL612545;;
CLD0;;;CHEMBL2345818;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of SYBR from phage lambda DNA by FID assay;CHEMBL2331546;Default value - Target has yet to be curated;U;556570;1;CHEMBL612545;;
CLD0;;;CHEMBL2345819;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of YOYO1 from phage lambda DNA by FID assay;CHEMBL2331546;Default value - Target has yet to be curated;U;556569;1;CHEMBL612545;;
CLD0;;DA-3 cell line;CHEMBL2345820;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307940;Target assigned is non-molecular;1;Cytotoxicity against mouse DA-3 cells assessed as reduction in cell viability at 20 uM by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556485;1;CHEMBL3879801;;
CLD0;;ES2;CHEMBL2345824;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human ES2 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556460;1;CHEMBL3879801;;
CLD0;;DA-3 cell line;CHEMBL2345825;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307940;Target assigned is non-molecular;1;Cytotoxicity against mouse DA-3 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556459;1;CHEMBL3879801;;
CLD0;;SK-OV-3;CHEMBL2345826;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556417;1;CHEMBL614925;;
CLD0;;MCF7;CHEMBL2345827;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556418;1;CHEMBL387;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354282;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652106;7;CHEMBL6152;;
CLD0;confirmatory;;CHEMBL2354287;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652104;7;CHEMBL2362981;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;;CHEMBL2387975;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of TEM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins relative to control;CHEMBL2384921;Default value - Target has yet to be curated;U;572931;1;CHEMBL612545;;
CLD0;;;CHEMBL2387976;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of TEM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins;CHEMBL2384921;Default value - Target has yet to be curated;U;572930;1;CHEMBL612545;;
CLD0;;;CHEMBL2387977;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of NDM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins relative to control;CHEMBL2384921;Default value - Target has yet to be curated;U;572929;1;CHEMBL612545;;
CLD0;;;CHEMBL2387978;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of NDM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins;CHEMBL2384921;Default value - Target has yet to be curated;U;572928;1;CHEMBL612545;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3214953;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;743255;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215046;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720708;7;CHEMBL2029198;;
CLD0;confirmatory;;CHEMBL3215079;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720707;7;CHEMBL2029197;;
CLD0;confirmatory;;CHEMBL3215169;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720533;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215185;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720538;7;CHEMBL2193;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215278;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720504;7;CHEMBL3024;;
CLD0;confirmatory;;CHEMBL3215284;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720559;7;CHEMBL2487;;
CLD0;confirmatory;;CHEMBL3214850;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter).   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720573;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214906;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720711;7;CHEMBL2029198;;
CLD0;confirmatory;;CHEMBL3214909;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743205;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214967;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720709;7;CHEMBL2029197;;
CLD0;confirmatory;;CHEMBL3214970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743244;7;CHEMBL612545;;
CLD0;;K562;CHEMBL3385481;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 72 hrs;CHEMBL3352802;Non-molecular target assigned;N;718347;1;CHEMBL385;;
CLD0;;;CHEMBL3508172;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 't1/2', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 't1/2', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Terminal half-life of 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1.0 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;189;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508174;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 't1/2', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 't1/2', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Terminal half-life ratio of 13-dihydrometabolite of 4-dem-daunorubicin to 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;191;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508179;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Volume of distribution', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Volume of distribution', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution of 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1.0 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;196;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508192;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Plasma clearance', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma clearance', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Plasma clearance of 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1.0 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;209;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508194;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Plasma clearance', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma clearance', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Plasma clearance ratio of 13-dihydrometabolite of 4-dem-daunorubicin to 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;211;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508203;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'AUC', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'AUC', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;AUC of 4-dem-daunorubicin following intravenous 4-dem-daunorubicin at 1.0 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;224;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508267;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mortality', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mortality', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Toxicity', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Toxicity', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '13.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '13.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mortality occurred following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;289;28;CHEMBL612545;;
CLD0;;;CHEMBL3508270;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Leukocyte count', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Leukocyte count', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '8.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Blood;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in leukocytes observed following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;292;28;CHEMBL612545;CHEMBL3638178;
CLD0;;;CHEMBL3508271;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Leukocyte count', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Leukocyte count', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Blood;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in leukocytes observed following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;293;28;CHEMBL612545;CHEMBL3638178;
CLD0;;;CHEMBL3508273;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in triglyceride', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in triglyceride', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum triglycerides level following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;295;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508274;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in triglyceride', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in triglyceride', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum triglycerides level following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;296;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508277;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in total cholesterol', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in total cholesterol', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum total cholesterol level following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;299;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508278;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in total cholesterol', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in total cholesterol', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum total cholesterol level following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;300;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508281;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in phospholipid', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in phospholipid', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum phospholipid level following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;303;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508282;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in phospholipid', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in phospholipid', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '8-22', 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '8-22', 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase in serum phospholipid level following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Non-molecular target assigned;N;304;28;CHEMBL3879801;CHEMBL3638229;
CLD0;;;CHEMBL3508285;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Incidence of persistent proteinuria', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Incidence of persistent proteinuria', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Clinical chemistry', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Clinical chemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Incidence of persistent proteinuria following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;307;28;CHEMBL612545;;
CLD0;;;CHEMBL3508286;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Incidence of persistent proteinuria', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Incidence of persistent proteinuria', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Clinical chemistry', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Clinical chemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Incidence of persistent proteinuria following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;308;28;CHEMBL612545;;
CLD0;;;CHEMBL3508289;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Incidence of leukocyturia', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Incidence of leukocyturia', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Clinical chemistry', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Clinical chemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Incidence of leukocyturia following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;311;28;CHEMBL612545;;
CLD0;;;CHEMBL3508290;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Incidence of leukocyturia', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Incidence of leukocyturia', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Clinical chemistry', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Clinical chemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Incidence of leukocyturia following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;312;28;CHEMBL612545;;
CLD0;;;CHEMBL3508293;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in albumin', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in albumin', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in albumin due to persistent proteinuria following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;315;28;CHEMBL612545;CHEMBL3638229;
CLD0;;;CHEMBL3508294;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Change in albumin', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Change in albumin', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '0.6'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Once per week', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Once per week', 'type': 'REGIMEN', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '36.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Serum;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in albumin due to persistent proteinuria following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;316;28;CHEMBL612545;CHEMBL3638229;
CLD0;;;CHEMBL3508407;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Leukocyte count', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Leukocyte count', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Low', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Low', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Blood;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in leukocytes observed following intravenous idarubicin at 0.3 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;476;28;CHEMBL612545;CHEMBL3638178;
CLD0;;;CHEMBL3508408;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Leukocyte count', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Leukocyte count', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Hematology', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Hematology', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468089.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468089.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intermediate', 'standard_type': 'DOSE_LEVEL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intermediate', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mixed', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mixed', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '36.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '36.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SAMPLING_TIME', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '8.0', 'text_value': None, 'type': 'SAMPLING_TIME', 'units': 'Week', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0/0.3/0.6/1', 'standard_type': 'STUDY_DOSES', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '0/0.3/0.6/1', 'type': 'STUDY_DOSES', 'units': 'mg.Kg-1', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '7.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '7.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Multiple_Inv_toxicity_rat', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple_Inv_toxicity_rat', 'type': 'STUDY_ID', 'units': None, 'value': None}];SD;;10116.0;In vivo;Blood;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Decrease in leukocytes observed following intravenous idarubicin at 0.6 mg.Kg-1 per week in rat;CHEMBL3508140;Default value - Target has yet to be curated;U;477;28;CHEMBL612545;CHEMBL3638178;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3561978;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117325;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3561991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117349;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562024;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117324;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562026;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117347;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117337;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562115;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117348;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562120;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117351;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3562121;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117327;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562139;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117350;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562146;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117305;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562152;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117312;7;CHEMBL612545;;
CLD0;;;CHEMBL3706548;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2582830.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2582830.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;9606.0;In vivo;Urine;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Percentage of administered dose recovered as unchanged drug in urine after intravenous administration;CHEMBL3706496;Default value - Target has yet to be curated;U;4;31;CHEMBL612558;CHEMBL3638201;
CLD0;;;CHEMBL3706549;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2582830.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2582830.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Idarubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Idarubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;9606.0;In vivo;Urine;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Percentage of administered dose recovered as unchanged drug in urine after oral administration;CHEMBL3706496;Default value - Target has yet to be curated;U;5;31;CHEMBL612558;CHEMBL3638201;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
2;;;CHEMBL3885883;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Single', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Single', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 10 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
GP_020;;;CHEMBL4296184;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_001;;;CHEMBL4296185;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
GN_034;;;CHEMBL4296188;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
MA_007;;HEK293;CHEMBL4296191;[];Homo sapiens;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Cell Viability', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Cell Viability', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Fluorescence (ex560/em590)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Fluorescence (ex560/em590)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'DMEM with 10% FBS', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'DMEM with 10% FBS', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; TC; CORNING #3712', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; TC; CORNING #3712', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC CRL1573;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614818;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
2_LEY;;Vero C1008;CHEMBL4513083;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of VERO-E6 cells after 48 hours  exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
3_LEY;;Vero C1008;CHEMBL4513084;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295411;Target assigned is non-molecular;1;Toxicity CC50 against VERO-E6 cells determined at 48 hours by high content imaging (same conditions as 2_LEY without exposure to 0.01 MOI SARS CoV-2 virus);CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303840;;
4_LEY;;Vero C1008;CHEMBL4513085;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295411;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity index (CI): selectivity for inhibition of SARS-CoV-2 induced cytotoxicity of VERO-E6 cells versus toxicity against VERO-E6 cells (CC50/IC50);CHEMBL4495565;Default value - Target has yet to be curated;U;;52;CHEMBL612558;;
1238467;;BJ;CHEMBL4671174;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as growth inhibition at 58 uM after 72 hrs by SYBR Gren-I fluorescent dye based method;CHEMBL4665821;Non-molecular target assigned;N;;1;CHEMBL364;;
1230911;;;CHEMBL4672894;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of recombinant His6-tagged SARS-CoV-2 main protease assessed as residual enzyme activity at 100 uM using Dabcyl-KTSAVLQ-SGFRKM-E(Edans-NH2) as substrate preincubated for 15 mins followed by substrate addition by FRET based assay relative to control;CHEMBL4665896;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1230912;;;CHEMBL4672895;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of recombinant His6-tagged SARS-CoV-2 main protease using Dabcyl-KTSAVLQ-SGFRKM-E(Edans-NH2) as substrate preincubated for 15 mins followed by substrate addition by FRET based assay;CHEMBL4665896;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1264775;;BJ;CHEMBL4724758;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;Cytotoxicity against human BJ cells assessed as reduction in cell viability at 58 uM by relative to control;CHEMBL4715909;Non-molecular target assigned;N;;1;CHEMBL614358;;
1315362;;BJ;CHEMBL4813750;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307781;Target assigned is non-molecular;1;Cytotoxicity against human BJ cells assessed as reduction in cell viability at 58 uM;CHEMBL4811310;Non-molecular target assigned;N;;1;CHEMBL614358;;
